Meelan Bul

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.

Journal: Investigative radiology

Published: November 14, 2013

Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.

Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.

Journal: The Canadian journal of urology

Published: June 21, 2013

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality.

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality.

Journal: Journal of medical screening

Published: October 25, 2012

Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*.

Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*.

Journal: BJU international

Published: October 10, 2012

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

Journal: European urology

Published: September 12, 2012

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.

Journal: BJU international

Published: August 30, 2012

Active surveillance for low-risk prostate cancer.

Active surveillance for low-risk prostate cancer.

Journal: Critical reviews in oncology/hematology

Published: May 02, 2012

The Prostate cancer Research International: Active Surveillance study.

The Prostate cancer Research International: Active Surveillance study.

Journal: Current opinion in urology

Published: March 29, 2012

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.

Journal: BJU international

Published: February 01, 2012

Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality.

Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality.

Journal: The Canadian journal of urology

Published: December 15, 2011

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study.

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study.

Journal: European urology

Published: December 12, 2011

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program.

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program.

Journal: European urology

Published: May 03, 2011

Showing 1-12 of 13

Last Updated: 09/26/2026